cognitive cybersecurity intelligence
A Food and Drug Administration (FDA) advisory panel has approved an epinephrine nasal spray, clearing a hurdle for the product designed to help those with severe, potentially life-threatening allergic reactions.
The panel, the Pulmonary-Allergy Drugs Advisory Committee, voted on Thursday…
Source: thehill.com – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Microsoft Warns Of XCSSET MacOS Malware That Is Now More Dangerous Than Ever HotHardware
New Malvertising Campaign Delivers Fake Microsoft Teams with Oyster Backdoor WebProNews
In today’s enterprise world, AI no longer just answers questions or writes emails, but it takes action. From copilots booking travel to intelligent agents updating
China-Linked Hackers Target Asian Telecoms, ASEAN with PlugX and Bookworm Malware WebProNews
